Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response-Reference-Cited by-同舟云学术

Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response

Published:2018-05-23 Issue:12 Volume:32 Page:2590-2603
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Sakamoto Kana,Katayama Ryohei^ORCID,Asaka Reimi,Sakata Seiji,Baba Satoko,Nakasone Hideki,Koike Sumie,Tsuyama Naoko,Dobashi Akito,Sasaki Makoto,Ichinohasama Ryo,Takakuwa Emi,Yamazaki Rie,Takizawa Jun,Maeda Takahiro,Narita Miwako,Izutsu Koji,Kanda Yoshinobu,Ohshima Koichi,Takeuchi Kengo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0154-5.pdf

Reference50 articles.

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edn. Lyon: IARC; 2017.

2. Leroux D. CD4+, CD56+DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood. 2002;99 :4154–9.

3. Dijkman R, van Doorn R, Szuhai K, Willemze R, Vermeer MH, Tensen CP. Gene-expression profiling and array-based CGH classify CD4 + CD56 + hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood. 2007;109:1720–7.

4. Lucioni M, Novara F, Fiandrino G, Riboni R, Fanoni D, Arra M, et al. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood. 2011;118:4591–4.

5. Wiesner T, Obenauf AC, Cota C, Fried I, Speicher MR, Cerroni L. Alterations of the cell-cycle inhibitorsp27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms. J Invest Dermatol. 2010;130:1152–7.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing the understanding and management of blastic plasmacytoid dendritic cell neoplasm: Insights from recent case studies;World Journal of Clinical Cases;2024-11-06

2. VPS34-IN1 inhibits cap-mediated translation and synergizes with STING to drive type-I IFN expression in human plasmacytoid DCs;2024-06-20

3. Myeloid sarcoma with plasmacytoid dendritic cell-like proliferation associated with IKZF1, ETV6 and DNMT3A mutations;International Journal of Hematology;2024-06-11

4. Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features;Leukemia;2024-04-10

5. Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCNs);Pediatric Pathology of Hematopoietic and Histiocytic Disorders;2024-02-15